Biktarvy, formally known as bictegravir sulfate, includes a potent single-tablet therapy for managing HIV infection. This drug integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the HIV's ability to multiply within the body, significantly lowering the viral load. For many indivi